Icaritin,the most effective metabolites of icariin isolated from traditional Chinese medicinal plants,has potential clinical application for its strong osteogenic activity. However,the mechanism of action, especially the receiving structure on cell surface and the receptor for icaritin, remain uncler despite the possible role as a phytoestrogen and reported effects on BMP, MAPK and WNT pathways.Basing on the research progress of non-genomic estrogen receptor pathways and the results obtained in our recent experiments, we here hypothesized that icaritin may bind with estrogen receptors or non-estrogen receptors located on plasma membrane and initiate osteogenic differentiation in the dependence of primary cilia,the recently identified non-motile sensory organelles on the surface of most mammalian cells.To verify our hypothesis and clarify the full-length signal transduction pathways, we are going to chemically label icaritin with biotin, which has high affinity with streptavidin, and then treat the bone cells with biotinylated icaritin (Bio-I), the conjugate of icartin and biotin. Since the greatly increased hydrophilicity, Bio-I would be impermeable in membrane and its distribution on bone cells would be demonstrated by immunofluorescence using fluorescein conjugated streptavidin. The icaritin-binding proteins would be fished out from the plasma membrane fractions in application of the high affinity between biotin and streptavidin conjugated with magnetic beads. The fished proteins would be identified by mass spectrum and the proteins functioning as receptors may be the receptors of icaritin. Their distribution and the combined interacting proteins would be determined by immunofluorescence under laser confocal microscope. All the above works, together with the related publications and our previous experimental results, would help to speculate the downstream signal transduction cascades. Finally, the speculated pathways would be verified by blocking with antagonists or RNA interference step by step.We have established the synthesis method for biotinylated icaritin and successfully showed the distribution of biotinylated icariin with immunofluorescence.As a result, icaritin was found to be located in the primary cilium, and its bone-formation promoting effect dispearred when the primary cilia of rat calvarial osteoblasts was removed by RNA interterference.This excting results,combined with our finding on the associations between increased intracellular cAMP, cGMP, NO and Ca2+ concentration and icaritin-induced osteogenic differentiation,make us believe that we would discover more than one signal transduction pathway which begin from the arrival of icaritin at bone cell surface and ending at the initiation of osteogenic differentiation. All we do would be extremely helpful to the development of new anti-osteoporosis drugs from the natural products including flavonoids.
淫羊藿素是一种具有强烈促进骨形成活性的中草药单体,应用前景广阔,但除作为植物雌激素和对BMP、MAPK、WNT等信号途径的影响外,其作用机制尚不明确,尤其缺乏作用靶点的研究报道。我们基于前期研究结果推测,淫羊藿素通过与位于细胞膜的雌激素受体或非雌激素受体结合而启动下游信号级联反应,在此过程中初级纤毛发挥了不可或缺的作用。为证明上述假说并阐明信号转导途径,本项目拟合成生物素化淫羊藿素并利用其不能自由通过细胞膜但仍具有促骨活性的特点开展以下研究:⒈进行免疫荧光示踪;⒉将生物素化淫羊藿素磁珠应用于免疫共沉淀,从质膜蛋白中钓出淫羊藿素受体及其复合蛋白;⒊进行质谱鉴定并根据鉴定结果和文献报道推测出促骨信号转导途径;⒋用逐步阻断法验证并确立至少一条完整的信号转导途径;⒌明确初级纤毛在该途径中的作用及机制。本项目已建立生物素化淫羊藿素的合成方法,研究结果将促进以天然产物为先导化合物的抗骨质疏松新药研发。
淫羊藿苷是中草药淫羊藿的主要有效成分之一,已知其能够促进骨形成和抑制骨吸收,具有开发为抗骨质疏松新药的潜在价值。但淫羊藿苷抗骨质疏松的作用机制至今不明,其受体为何尚不清楚。本项目提出利用淫羊藿素的羟基与生物素的羧基发生成酯反应,合成生物素化淫羊藿素(Bio-I),然后基于生物素与链霉亲和素的高亲和力而发展出针对Bio-I的免疫荧光染色和免疫共沉淀技术,用以显示淫羊藿苷进入成骨细胞后的轨迹及钓取淫羊藿苷的受体蛋白等,并进而找到至少一条新的淫羊藿苷促进骨形成的信号转导途径。本项目已按计划完成大部分研究任务,取得如下重要成果:1.成功合成3,7-二生物素淫羊藿素(Bio-I),并确认其促进骨形成活性无显著下降;2.成功建立基于Bio-I的免疫荧光染色技术,并用此技术观察了Bio-I进入成骨细胞后的运动轨迹。发现其大部分时间分布于细胞核周围,但始终未进入细胞核内部;3.用挂了Bio-I的免疫磁珠钓取到与Bio-I结合的蛋白质,并进行质谱分析及western blot鉴定;4.用GE公司开发的Biacore技术钓取与Bio-I结合的蛋白质,经质谱分析发现,至少含有146种蛋白质,确定一种分子量为47KD的未知蛋白具有潜在研究价值;5.发现CXCR4也位于钓取蛋白之列,其表达量呈现明显的先增加后逐渐衰减的变化趋势,如用特异性阻断剂AMD3100预处理成骨细胞,则淫羊藿苷促进骨形成活性完全消失,从而首次发现淫羊藿苷通过SDF-1/CXCR4信号途径促进骨形成。6.未观察到Bio-I进入初级纤毛,Bio-I与初级纤毛在空间分布上无明显交集。如用RNA干扰法抑制初级纤毛发生,则淫羊藿苷促进骨形成活性消失,说明初级纤毛为淫羊藿苷促进骨形成所必需;7.发现淫羊藿苷通过初级纤毛调控的sAC/cAMP/PKA/CREB信号途径促进骨形成,其中sAC和p-PKA均被定位于初级纤毛内;8.淫羊藿苷或淫羊藿总黄酮可提高生长期大鼠的峰值骨量,其作用机制是通过sAC/cAMP/PKA/ CREB信号途径促进骨形成,而对骨吸收则无明显影响。本项目初步阐明了淫羊藿苷促进骨形成的信号转导机制,对今后以淫羊藿苷为先导化合物的抗骨质疏松新药研发具有重要指导意义。
{{i.achievement_title}}
数据更新时间:2023-05-31
基于一维TiO2纳米管阵列薄膜的β伏特效应研究
转录组与代谢联合解析红花槭叶片中青素苷变化机制
莱州湾近岸海域中典型抗生素与抗性细菌分布特征及其内在相关性
黑河上游森林生态系统植物水分来源
TGF-β1-Smad2/3信号转导通路在百草枯中毒致肺纤维化中的作用
淫羊藿素和淫羊藿苷合成途径解析及微生物细胞工厂构建研究
中期因子促进肿瘤的分子机制及其下游信号转导系统鉴定
淫羊藿次甙Ⅱ调控骨保护素的表达及机制研究
一条全新的细菌生物素前体的生物合成途径研究